Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Clagett, US

Bill Clagett, Elizabethtown, KY US

Patent application numberDescriptionPublished
20100120402System and Method for Enhanced Content Access - As Mobile Subscribers increasingly employ their Wireless Devices to access an ever expanding universe of content—anything including but not limited to for example WWW pages, JavaScript, ActiveX, static images, audio, video, streaming audio/video, data, software applications, etc.—an infrastructure that supports seamless access to content by addressing a range of challenges that arise during such interactions including, for example, the proper identification of content, the timely retrieval of content from a variety of sources, the processing and persistence of content, the delivery of content, etc. The infrastructure may optionally leverage the capabilities of a centrally-located Messaging Inter-Carrier Vendor.05-13-2010

James Clagett, Snohomish, WA US

Patent application numberDescriptionPublished
20080214472Small Peptides And Methods For Treatment Of Arthritis - Methods for treating cutaneous inflammation, are described. Also described is a method for inhibiting the mucous release into airways of a patient, a method for blocking IgE activation of a lymphocyte, a method for stabilizing the cell membrane of a lymphocyte, thereby preventing their further involvement in the increased inflammatory response to an IgE antigen challenge, and a method for inhibiting the migration of T-cells. Such methods involve administering to said patient a therapeutically effective amount of a peptide having the formula f-Met-Leu-X, wherein X is selected from the group consisting of Tyr, Tyr-Phe, Phe-Phe and Phe-Tyr.09-04-2008
20080214473Small Peptides And Methods For Treatment Of Chronic Obstruction Pulmonary Disease - Methods for treating cutaneous inflammation, are described. Also described is a method for inhibiting the mucous release into airways of a patient, a method for blocking IgE activation of a lymphocyte, a method for stabilizing the cell membrane of a lymphocyte, thereby preventing their further involvement in the increased inflammatory response to an IgE antigen challenge, and a method for inhibiting the migration of T-cells. Such methods involve administering to said patient a therapeutically effective amount of a peptide having the formula f-Met-Leu-X, wherein X is selected from the group consisting of Tyr, Tyr-Phe, Phe-Phe and Phe-Tyr.09-04-2008
20080214474Small Peptides And Methods For Treatment Of Chronic Inflammatory Bowel Disease - Methods for treating cutaneous inflammation, are described. Also described is a method for inhibiting the mucous release into airways of a patient, a method for blocking IgE activation of a lymphocyte, a method for stabilizing the cell membrane of a lymphocyte, thereby preventing their further involvement in the increased inflammatory response to an IgE antigen challenge, and a method for inhibiting the migration of T-cells. Such methods involve administering to said patient a therapeutically effective amount of a peptide having the formula f-Met-Leu-X, wherein X is selected from the group consisting of Tyr, Try-Phe, Phe-Phe and Phe-Tyr.09-04-2008
20080214475Small Peptides And Methods For Inhibiting The Mucous Release Into Airways - Methods for treating cutaneous inflammation, are described. Also described is a method for inhibiting the mucous release into airways of a patient, a method for blocking IgE activation of a lymphocyte, a method for stabilizing the cell membrane of a lymphocyte, thereby preventing their further involvement in the increased inflammatory response to an IgE antigen challenge, and a method for inhibiting the migration of T-cells. Such methods involve administering to said patient a therapeutically effective amount of a peptide having the formula f-Met-Leu-X, wherein X is selected from the group consisting of Tyr, Tyr-Phe, Phe-Phe and Phe-Tyr.09-04-2008
20080214476Small Peptides And Methods For Blocking IgE Mediated Activation Of An Immune Cell - Methods for treating cutaneous inflammation, are described. Also described is a method for inhibiting the mucous release into airways of a patient, a method for blocking IgE activation of a lymphocyte, a method for stabilizing the cell membrane of a lymphocyte, thereby preventing their further involvement in the increased inflammatory response to an IgE antigen challenge, and a method for inhibiting the migration of T-cells. Such methods involve administering to said patient a therapeutically effective amount of a peptide having the formula f-Met-Leu-X, wherein X is selected from the group consisting of Tyr, Tyr-Phe, Phe-Phe and Phe-Tyr.09-04-2008
20080214477Small Peptides And Methods For Inhibiting The Migration Of T-Cells - Methods for treating cutaneous inflammation, are described. Also described is a method for inhibiting the mucous release into airways of a patient, a method for blocking IgE activation of a lymphocyte, a method for stabilizing the cell membrane of a lymphocyte, thereby preventing their further involvement in the increased inflammatory response to an IgE antigen challenge, and a method for inhibiting the migration of T-cells. Such methods involve administering to said patient a therapeutically effective amount of a peptide having the formula f-Met-Leu-X, wherein X is selected from the group consisting of Tyr, Tyr-Phe, Phe-Phe and Phe-Tyr.09-04-2008
20080214478Small Peptides And Methods For Inhibiting The Infiltration Of Eosinophils Into Airways - Methods for treating cutaneous inflammation, are described. Also described is a method for inhibiting the mucous release into airways of a patient, a method for blocking IgE activation of a lymphocyte, a method for stabilizing the cell membrane of a lymphocyte, thereby preventing their further involvement in the increased inflammatory response to an IgE antigen challenge, and a method for inhibiting the migration of T-cells. Such methods involve administering to said patient a therapeutically effective amount of a peptide having the formula f-Met-Leu-X, wherein X is selected from the group consisting of Tyr, Tyr-Phe, Phe-Phe and Phe-Tyr.09-04-2008

James A. Clagett, Snohomish, WA US

Patent application numberDescriptionPublished
20110160857METHODS FOR COLLECTING AND PROCESSING AUTOGRAFTS, PROCESSED AUTOGRAFTS, KITS FOR COLLECTING AND TRANSPORTING AUTOGRAFTS, AND TOOLS FOR PREPARING AUTOGRAFTS - The present invention is directed to methods for collecting and processing autografts, processed autografts, kits for collecting and transporting autografts, and tools for preparing autografts. It is also directed to autologous bone grafts, and methods of preparing them.06-30-2011

Scott Clagett, Wake Forest, NC US

Patent application numberDescriptionPublished
20080242271ELECTRONIC DEVICE WITH LOCATION-BASED AND PRESENCE-BASED USER PREFERENCES AND METHOD OF CONTROLLING SAME - A method of controlling preferences of a mobile telephone includes associating one or more user-settable preferences with a location or geographic area. The one or more preferences is applied to operation of the mobile telephone when the mobile telephone is at the location or geographic area. In one embodiment, the method includes associating one or more user-settable preferences with an electronic device having a known identity; detecting presence of the electronic device; and applying the one or more preferences associated with the electronic device to operation of the mobile telephone. In another embodiment, the method includes associating one or more user-settable preferences with a segment of time; and during the segment of time, applying the one or more preferences associated with the segment of time to operation of the mobile telephone.10-02-2008
20080242372ELECTRONIC DEVICE WITH LOCATION-BASED AND PRESENCE-BASED PHYSICAL ATTRIBUTES AND METHOD OF CONTROLLING SAME - A mobile telephone includes a radio circuit for establishing a call over a communications network. The mobile telephone also includes a housing that retains the radio circuit and an illumination assembly. The illumination assembly is controlled to generate light in a color having a user specified relationship to a location of the mobile telephone. In one embodiment, the illumination assembly is controlled to generate light in a color having a user specified relationship to an electronic device that is detected to be in relative proximity to the mobile telephone.10-02-2008